EUCTR2007-004541-15-DE进行中（未招募）不适用
A Randomized Controlled Open-Label Phase IV Mono Center Study to Compare the Reponse Profiles of Montelukast versus Fluticason in Children with Preschool Asthma - leucotrienantagonists or steroids in preschool asthma
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •diagnosis of moderate bronchial asthma (GINA level I-II) in last 12 months
- •usage of Beta-2-Agonists < 1/ week (max. 3 puffs/day)
- •> 4 weeks without exacerbations before Visite 1
- •written informed consent of parents / guardians
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •chronic persisting asthma with regular inhalative steroid and/or Montelukast therapy
- •patients age < 4 or > 7 years
- •missing cooperation in the performance of lung function
- •exazerbation within 28 days before visite 1
- •other severe disease conditions (e.g., cystic fibrosis, psychiatric disorders, neoplasms or history of immunosuppression)
- •participation in other clinical trials < 30 days before the study
研究者
相似试验
进行中（未招募）
不适用
A Randomized Controlled Open-Label Phase IV Multi Center Study to Assess the Effect of Antipyretic Prophylactic Treatment on the Rate of Febrile Reactions Following Concomitant Contralateral Administration of a 7-Valent Pneumococcal Conjugate Vaccine (Prevenar®) and DTPa-HBV-IPV+Hib Vaccine (Infanrix hexa®) in Children at 2, 3, 4 and 11-14 Months of Age. - Prevenar Antipyretic TrialEUCTR2004-000397-31-DEWyeth Vaccines Research300
进行中（未招募）
1 期
DREAM studyEUCTR2016-004646-29-ESFundación SEIMC-GESIDA64
进行中（未招募）
1 期
A prospective, randomised, phase IV, open label clinical trial to study the therapeutic use of buprenorphine 20 mg (BuTrans 20µg/h) matrix transdermal patch in the management of post tonsillectomy pain in adults - PATCH TrialEUCTR2007-006117-16-GBBetsi Cadwaladr University Health Board300
已完成
4 期
A study to check whether addition of Resveratrol is beneficial and safe in patients with Diabetes, Dyslipidemia and Hypertension (who are already on standard therapy)CTRI/2017/04/008384Rakesh Ojha180
进行中（未招募）
不适用
A Phase 4, Open Label, Randomized, Controlled Study to Assess the Effect on Lipid Profile of Switching from a Stable HAART Regimen of fixed dose Abacavir/Lamivuidine (Kivexa) Plus Efavirenz, to Once Daily Atripla in Adult HIV-1 Infected Subjects With Raised Cholesterol - ROCKET - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation TrialEUCTR2007-003354-28-GBGilead Sciences Limited